Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANVS
#3484
Annovis Bio, Inc.
2.6
9
-2.54%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-2.54%
Monthly Change
-9.12%
6 month change
+14.47%
Year Change
+46.20%
Previous Close
2.7
6
Open
2.6
6
Bid
Ask
Low
2.6
6
High
2.6
9
Volume
28
Markets
US Stock Market
Healthcare
ANVS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)
Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion
Annovis Bio raises $3.4 million in registered direct offering
Annovis Bio raises $6 million in registered direct offering
Annovis Bio reports buntanetap reduces inflammation in Alzheimer’s patients
Canaccord Genuity reaffirms Buy rating on Annovis Bio stock